Pharmaceuticals
-
AstraZeneca wins rapid regulatory approval for new uses of two of its important cancer drugs in Japan
Jul 2, 2018AstraZeneca has won rapid regulatory approval for new uses of two of its important cancer drugs in Japan, less than six months after the first global approvals in Western markets. The decisions by the Japanese Ministry... -
European Medicines Agency likely to give positive opinion on breast cancer drug of Puma Biotech
Jun 26, 2018Puma Biotechnology Inc said on Tuesday a committee of the European Medicines Agency was likely to give positive opinion on its breast cancer drug, five months after the regulator recommended against approving it. Puma shares were... -
Roche to pay $2.4 billion to buy the rest of Foundation Medicine
Jun 19, 2018Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine (FMI), raising its bet on the U.S. genomic profiling group’s ability to personalize cancer care. The deal, backed by the boards of... -
Teva Pharmaceutical Inc to discontinue a trial testing its drug for the treatment of chronic cluster headache
Jun 16, 2018Israel’s Teva Pharmaceutical Inc said on Friday it would discontinue a trial testing its drug for the treatment of chronic cluster headache, after an analysis showed that the drug was unlikely to meet the study’s main... -
Real-world evidence shows clinically meaningful weight loss in people receiving Saxenda®
May 25, 2018People treated with Saxenda® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. The data were presented this week... -
Eli Lilly and Co to buy Armo BioSciences Inc for about $1.6 billion
May 11, 2018Eli Lilly and Co said on Thursday it would buy Armo BioSciences Inc for about $1.6 billion to expand its portfolio of drugs that helps body’s immune system fight cancer as the U.S. drugmaker chases rivals... -
Regeneron Pharmaceuticals Inc and Sanofi SA to slash the price of cholesterol drug for Express Scripts Holdings Co customers
May 2, 2018Regeneron Pharmaceuticals Inc and Sanofi SA will slash the price of their expensive cholesterol drug for Express Scripts Holdings Co customers in exchange for greater patient access, with some savings to be shared with consumers, the... -
Novartis launches FocalView app
Apr 25, 2018Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data directly from consenting patients. By adapting... -
Shire to recommend a new $64 billion takeover bid by Takeda to its shareholders
Apr 25, 2018The board of Irish pharmaceutical company Shire will recommend a new o46 billion ($64 billion) takeover bid by Japanese firm Takeda to its shareholders, it said in a statement released on Tuesday night. The decision comes... -
Sanofi Head of Global R&D Elias Zerhouni to retire
Apr 24, 2018Elias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the post by...
